T1	Outcomes 66 82	glycemic control
T2	Outcomes 87 114	pancreatic β-cell function
T3	Outcomes 286 298	the efficacy
T4	Outcomes 699 700	.
T5	Outcomes 701 734	Preservation of insulin secretion
T6	Outcomes 745 789	by mixed-meal-stimulated C-peptide secretion
T7	Outcomes 866 1004	in glycosylated hemoglobin (HbA1c), continuous glucose sensor data, insulin utilization, anthropometric measures, and patient satisfaction
T8	Outcomes 1150 1210	higher mixed-meal tolerance test-stimulated C-peptide values
T9	Outcomes 1307 1332	improved glycemic control
T10	Outcomes 1396 1434	with normoglycemia, better mean HbA1c)
T11	Outcomes 1485 1505	greater satisfaction
T12	Outcomes 1606 1631	improved glycemic control
T13	Outcomes 1637 1651	well tolerated
T14	Outcomes 1672 1701	improved patient satisfaction
T15	Outcomes 1790 1824	preserve residual β-cell function
